PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 63 filers reported holding PROQR THRAPEUTICS N V in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $93,000 | -4.1% | 124,424 | -0.7% | 0.09% | +5.7% |
| Q2 2022 | $97,000 | +142.5% | 125,273 | +185.4% | 0.09% | +225.9% |
| Q1 2022 | $40,000 | -81.4% | 43,900 | +63.3% | 0.03% | -80.9% |
| Q4 2021 | $215,000 | +17.5% | 26,875 | +23.1% | 0.14% | +21.6% |
| Q3 2021 | $183,000 | -15.3% | 21,830 | -31.9% | 0.12% | -15.9% |
| Q2 2021 | $216,000 | -5.7% | 32,037 | -7.6% | 0.14% | -11.0% |
| Q1 2021 | $229,000 | +241.8% | 34,654 | +118.6% | 0.16% | +244.4% |
| Q4 2020 | $67,000 | – | 15,855 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |